Novo Nordisk’s new weight-loss pill Amycretin beats Wegovy in early trial

The highly anticipated new obesity pill shows the potential for greater and faster weight loss than Wegovy.

There is a new chapter in Big Pharma’s billion-dollar war on obesity, as Novo Nordisk and Eli Lilly battle it out over the latest blockbuster drugs.